🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great talks today NCIC symposium today! Follow the tweets from Beatrice Sim. A privilege to hear from Norelle Sherry Andrew Karaba camwolfe William Werbel MD PhD Recording of talks and q&a will be available online shortly cancerandinfections.org

Dear LOR writers, it is possible to write a strong letter that is not more than 1 page. Please strive for this goal. Sincerely, a weary application reviewer. #AcademicTwitter #MedTwitter #IDtwitter

Please join us Thurs 10/13 at 3pm EDT for the inaugural #DavidandSuzanneThomasLectureship With #NobelPrize winner #harveyalter #HepC #HCV LEARN MORE: bit.ly/3R2nUZ9 LIVESTREAM: video.ibm.com/JHU-SOM

These were phenomenal presentations and really ground breaking work. PSP The Osler Medical Residency truly preparing amazing physician scientists. Having worked with these 3 I can tell you they are all great clinicians and clearly top-notch scientists too.

Dear COVID researchers, while we can’t seem to come to a consensus on what to call the ancestral strain (vaccine, WA-1, Wu-1, etc). Can we at least agree that it is NOT “wild-type?” All the circulating variants are wild-type. #virology #IDTwitter Stuart Ray William Werbel MD PhD

Great session on antifungals #IDWeek2022. Did not know aspergillosis survival remains ~70% no matter what drug we study. There is work to do. maricar malinis Shmuel Shoham Kieren Marr

Loving this session on late-breaking vaccine data at @IDWeek2022. Lots to be excited about regarding RSV prevention. Michael Ison, MD MS #virology

Great first talk on Maribavir for R/R CMV by Camille Nelson Kotton. So glad to have this as an option for our patients with this really frustrating virus. 🔑don't forget to use HSV/VZV prophy, watch for DDIs, can't use w/ GCV. @IDWeek2022 maricar malinis @PergamIC

Great talk by Michelle Yong on CMV immunity monitoring, but I wonder why these assays don't work better for all patients? My guess is CMV immunity/control is more complicated than we'd like. Abs? Antigens other than pp65/IE1? Innate immunity? differences in CMV strains? @IDWeek2022

First up in clinical controversies @IDWeek2022: @UWIDFellowship alumni all 💫💫 Olivia Kates, MD and Hannah Imlay debate vaccine mandates in SOT candidates 💉💪🏽

Excited for debate between Hannah Imlay and Olivia Kates, MD on SARS-CoV-2 vaccine requirements for #sot. Expecting the metaphorical gloves to come off! @IDWeek2022

This is a tour-de-force study on HSV-1 genital ifxn by Christine Johnston and colleagues UW Medicine. Lots we still don't know about differences between HSV-1 and HSV-2, but this helps clarify risk of transmission after 1st episode. #herpes #virology #IDtwitter jamanetwork.com/journals/jama/…

Very proud of my friend and nephrology rock-star Joshua Waitzman, MD PhD for being awarded Nephrology Journal Club MVP award American Society of Nephrology kidney week! He’s been teaching me things since M1 year Northwestern Feinberg School of Medicine and continues to this day.

I’ve seen no convincing evidence that SARS-CoV-2 infects T cells or depletes dendritic cells, particularly in vaccinated people. If someone has some evidence I’d be interested in seeing it.

The Emerging Pathogens of Concern (EPOC) research study (IRB0038184; Principal Investigator Dr. William Werbel) is live, studying infections & vaccines in immunocompromised persons & close contacts. Visit emergingpathogens.jhmi.edu or email [email protected] for more info!

Thanks to everyone who came out for our social tonight at #ATC2024Philly. Sorry if we missed you for the group pic - incredible turnout & awesome convos! Appreciate the continued support of TxID Early Career Network from #TxID community American Society of Transplantation (AST) Infectious Diseases Community of Practice - AST Please tag if we missed you!

Study in Clinical Infectious Diseases (bit.ly/4ePuNKo) by Johns Hopkins Medicine Johns Hopkins Division of Infectious Diseases finds booster doses of #BivalentVaccines given every 3-6 months helps maintain a person’s ability to neutralize multiple #SARSCoV2 strains, incl. XBB.1.5 (bit.ly/3VMMJN5). Andrew Karaba William Werbel MD PhD

Stewardship of diagnostics and therapeutics are under appreciated aspects of CMV disease.